BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 10699620)

  • 1. Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. The Prostate Study Group of the Austrian Society of Urology.
    Schatzl G; Brössner C; Schmid S; Kugler W; Roehrich M; Treu T; Szalay A; Djavan B; Schmidbauer CP; Söregi S; Madersbacher S
    Urology; 2000 Mar; 55(3):397-402. PubMed ID: 10699620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of vitamin D receptor and 17 hydroxylase gene polymorphisms with benign prostatic hyperplasia and benign prostatic enlargement.
    Schatzl G; Gsur A; Bernhofer G; Haidinger G; Hinteregger S; Vutuc C; Haitel A; Micksche M; Marberger M; Madersbacher S
    Urology; 2001 Mar; 57(3):567-72. PubMed ID: 11248649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between lower urinary tract symptoms and serum levels of sex hormones in men.
    Miwa Y; Kaneda T; Yokoyama O
    Urology; 2008 Sep; 72(3):552-5. PubMed ID: 18597822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible relationship between serum sex hormones and benign prostatic hyperplasia/lower urinary tract symptoms in men who underwent transurethral prostate resection.
    Wu Y; Pan H; Wang WM; Xu D; Zhang L; Gu ZQ; Bai Q; Qi J; Huang HF
    Asian J Androl; 2017; 19(2):230-233. PubMed ID: 26763548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine patterns in patients with benign and malignant prostatic diseases.
    Schatzl G; Reiter WJ; Thürridl T; Waldmüller J; Roden M; Söregi S; Madersbacher S
    Prostate; 2000 Aug; 44(3):219-24. PubMed ID: 10906738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms.
    Vesely S; Knutson T; Damber JE; Dicuio M; Dahlstrand C
    Scand J Urol Nephrol; 2003; 37(4):322-8. PubMed ID: 12944191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia.
    Tan MO; Karabiyik I; Uygur MC; Diker Y; Erol D
    Int Urol Nephrol; 2003; 35(3):357-63. PubMed ID: 15160539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between serum sex hormones levels and degree of benign prostate hyperplasia in Chinese aging men.
    Zeng QS; Xu CL; Liu ZY; Wang HQ; Yang B; Xu WD; Jin TL; Wu CY; Huang G; Li Z; Wang B; Sun YH
    Asian J Androl; 2012 Sep; 14(5):773-7. PubMed ID: 22751417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally.
    Tsukamoto T; Masumori N; Rahman M; Crane MM
    Int J Urol; 2007 Apr; 14(4):321-4; discussion 325. PubMed ID: 17470162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age, genetic, and nongenetic factors influencing variation in serum sex steroids and zonal volumes of the prostate and benign prostatic hyperplasia in twins.
    Meikle AW; Stephenson RA; Lewis CM; Wiebke GA; Middleton RG
    Prostate; 1997 Oct; 33(2):105-11. PubMed ID: 9316651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between benign prostatic hyperplasia/lower urinary tract symptoms and total serum testosterone level in healthy middle-aged eugonadal men.
    Lee JH; Kim Y; Park YW; Lee DG
    J Sex Med; 2014 May; 11(5):1309-15. PubMed ID: 24612680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower urinary tract symptoms, prostate volume and uroflow in norwegian community men.
    Overland GB; Vatten L; Rhodes T; DeMuro C; Jacobsen G; Vada K; Angelsen A; Girman CJ
    Eur Urol; 2001 Jan; 39(1):36-41. PubMed ID: 11173937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade prostate cancer is associated with low serum testosterone levels.
    Schatzl G; Madersbacher S; Thurridl T; Waldmüller J; Kramer G; Haitel A; Marberger M
    Prostate; 2001 Apr; 47(1):52-8. PubMed ID: 11304729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
    Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
    J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower urinary tract symptoms and uroflow in a community-based sample of Taiwanese men.
    Chen TI; Hsu YS; Wu TT
    J Chin Med Assoc; 2003 Feb; 66(2):84-8. PubMed ID: 12716005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of metabolic status on the association of serum vitamin D with hypogonadism and lower urinary tract symptoms/benign prostatic hyperplasia.
    Park SG; Yeo JK; Cho DY; Park MG
    Aging Male; 2018 Mar; 21(1):55-59. PubMed ID: 28414251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
    Roehrborn CG; Kaplan SA; Kraus SR; Wang JT; Bavendam T; Guan Z
    Urology; 2008 Nov; 72(5):1061-7; discussion 1067. PubMed ID: 18817961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do baseline estrogen and testosterone affect lower urinary tract symptoms (LUTS) prior to or after pharmacologic treatment with tadalafil?
    Egan KB; Miner MM; Suh M; McVary K; Ni X; Roehrborn CG; Wittert G; Wong DG; Rosen RC
    Andrology; 2015 Nov; 3(6):1165-72. PubMed ID: 26452447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
    Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
    Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score.
    Ezz el Din K; Kiemeney LA; de Wildt MJ; Debruyne FM; de la Rosette JJ
    Urology; 1996 Sep; 48(3):393-7. PubMed ID: 8804492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.